Skip to main content
SpringerLink
Log in

COMMENTARY: Psychomotor development in children and antenatal psychotropic andanti-epileptic drugs

  • Commentary
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Laegreid L, Hagberg G, Lundberg A. The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 1992; 23: 18–23.

    Google Scholar 

  2. Bergman U, Rosa FW, Baum C, Wiholm B-E, Faich GA. Effects of exposure to benzodiazepine during fetal life. Lancet 1992; 340: 694–696.

    Google Scholar 

  3. Barrett C, Richens A. Epilepsy and pregnancy: Report of an epilepsy research foundation workshop. Epilepsy Res 2003; 52: 147–187.

    Google Scholar 

  4. Dean J, Hailey H, Moore S, Lloyd D, Turnpenny P, Little J. Long-term health and neurodevelopment in children exposed to anti-epileptic drugs before birth. J Med Genet 2002; 39: 251–259.

    Google Scholar 

  5. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal anti-depressant exposure. Am J Psychiatr 2002; 159: 2055–2061.

    Google Scholar 

  6. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. Am J Psychiatr 2002; 159: 1889–1895.

    Google Scholar 

  7. Cohen LS, Jerrold FR. Psychotropic drug use during pregnancy: Weighing the risks. J Clin Psychiatr 1998; 59: 18–28.

    Google Scholar 

  8. Mortensen JT, Olsen J, Larsen H, Bendsen J, Obel C, Søensen HT. Psychomotor development in children exposed in utero to benzodiazepines, anti-depressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 2003.

  9. Mitchell AA. Special considerations in studies of drug-induced birth defects. In: Strom BL (ed), Pharmaco-epidemiology. NY: Wiley & Sons, 2000: 595–608.

    Google Scholar 

  10. Hernaán M, Hernaández-Díaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation. An application to birth defects epidemiology. Am J Epidemiol 2002; 155: 176–184.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Slone Epidemiology Center, Boston University, Boston, MA, USA

    Sonia Hernández-Díaz

  2. División de Farmacoepidemiología y Farmacovigilancia. Agencia Española del Medicamento, Madrid, Spain

    Francisco J. de Abajo

Authors
  1. Sonia Hernández-Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco J. de Abajo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hernández-Díaz, S., de Abajo, F.J. COMMENTARY: Psychomotor development in children and antenatal psychotropic andanti-epileptic drugs. Eur J Epidemiol 18, 743–744 (2003). https://doi.org/10.1023/A:1025351915128

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025351915128

Search

Navigation